1. Home
  2. AMST vs BRTX Comparison

AMST vs BRTX Comparison

Compare AMST & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amesite Inc.

AMST

Amesite Inc.

HOLD

Current Price

$1.16

Market Cap

7.4M

Sector

Technology

ML Signal

HOLD

Logo BioRestorative Therapies Inc. (NV)

BRTX

BioRestorative Therapies Inc. (NV)

HOLD

Current Price

$0.41

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMST
BRTX
Founded
2017
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.4M
6.3M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
AMST
BRTX
Price
$1.16
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
266.3K
25.4M
Earning Date
05-13-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
N/A
EPS
N/A
N/A
Revenue
$110,459.00
$81,000.00
Revenue This Year
N/A
$298.39
Revenue Next Year
N/A
$64.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$0.16
52 Week High
$4.78
$1.89

Technical Indicators

Market Signals
Indicator
AMST
BRTX
Relative Strength Index (RSI) 41.86 58.72
Support Level $0.88 $0.20
Resistance Level $2.12 $1.20
Average True Range (ATR) 0.10 0.05
MACD -0.03 -0.00
Stochastic Oscillator 0.03 78.45

Price Performance

Historical Comparison
AMST
BRTX

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: